This multi-center cross-sectional survey study included women who had been randomly selected from a 10-year cohort and who had previously undergone a mastectomy for breast cancer either followed by an autologous-BR, an implant-BR or who had not undergone BR. These women were asked to complete the reconstruction module of the Breast-Q, the EORTC-C30 and EORTC-BR23 quality of life questionnaires and the EQ-5D. Propensity score matching was used to compensate for selection bias originating from pretreatment differences between the patient groups.
INTRODUCTION:
Considerations of sexual wellbeing may impact a woman's decision about breast cancer surgery or reconstruction. We conducted a systematic review to clarify sexual well-being outcomes after breast cancer surgery.
METHODS:
We searched Medline, Embase, Cochrane, Scopus, and Web of Science for English-language studies about lumpectomy, mastectomy, and/or breast reconstruction in adult female breast cancer patients. Exclusion criteria included cosmetic procedures, non-cancer patients, <10 patients, and non-English language. Two authors independently screened titles/abstracts for eligibility. Data on sexual satisfaction, sexual function, and breast erogenous sensibility were extracted for a qualitative analysis of the literature. Meta-analysis was performed for validated questionnaires to quantitatively evaluate different surgical modalities.
RESULTS:
We identified 1193 studies after deduplication; 104 were eligible for data extraction. The most common study design was crosssectional (51, 49%). Only 47 studies (45%) used validated questionnaires. In meta-analysis of 3 studies (431 patients) using the Cancer Rehabilitation Evaluation System sexual subscale, there was no significant difference between lumpectomy and mastectomy-only for patient-reported sexual well-being (p=0.14). In meta-analysis of 2 studies (103 patients) using the Female Sexual Function Index, patients with reconstruction had higher scores for sexual function compared to mastectomy-only patients (p=0.02). Only 58 studies (56%) presented sexual outcomes for 2 or more surgical treatment groups. Of 26 studies directly comparing mastectomy-only with mastectomy+reconstruction, 10 favored reconstruction (higher sexual satisfaction/function), 3 favored mastectomy-only, and 13 found no significant difference. 16 studies compared lumpectomy with mastectomy+reconstruction: 6 favored lumpectomy, 2 favored mastectomy+reconstruction, and 8 found no significant difference. Of 25 studies comparing lumpectomy with mastectomy-only, 11 favored lumpectomy, 1 favored mastectomy, and 13 found no significant difference. 15 studies assessed sexual well-being after risk-reducing mastectomy with or without breast reconstruction; of these, only 3 (20%) compared 2 or more surgical treatments on a sexual outcome.
